The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients.
Scott Kopetz
No relevant relationships to disclose
Zhi-Qin Jiang
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Robert Rosenberg
Research Funding - Agendia
Ramon Salazar
Research Funding - Agendia
Josep Tabernero
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Ying Li
Employment or Leadership Position - Agendia
Iris Simon
Employment or Leadership Position - Agendia
George J. Chang
No relevant relationships to disclose
Dipen M. Maru
No relevant relationships to disclose